Genes and the environment: their impact on children's health. by Suk, W A & Collman, G W
Genes andthe Environment:
Their Impact on Children's Health
William A. Sukl and Gwen W. Collman2
10ffice of Program Development; 2Chemical Exposures and Molecular
Biology Branch, Division of Extramural Research and Training, National
Institute of Environmental Health Sciences, Research Triangle Park,
North Carolina
Because the human population is biologically diverse and genetically heterogeneous, it is not
surprising that differences in susceptibility to disease among individuals with or without exposure
to environmental agents exist. Individuals vary greatly in their susceptibility to disease. This is true
of adults and children. The etiologies of many diseases of childhood are due to a combination of
factors, including genetic susceptibility and environmental exposures during vulnerable periods of
,development. Genes regulate cellular growth and development, DNA replication and repair, the
metabolism of endogenous agents in the body, and the metabolism and excretion of exogenous
agents that the body comes in contact with in the environment. This regulation varies over the life
span, contributing to the cellular consequences of the environmental exposures. This paper
summarizes the contributions of genetics in understanding the etiology of environmentally induced
diseases in children. The use of biomarkers of genetic susceptibility in the study of these diseases
will be discussed. Future research needs for expanding our knowledge of the interactions
between genetic and environmental components of childhood diseases will be presented.
Environ Health Perspect 106(Suppl 3):817-820 (1998). http://ehpnetl.niehs.nih.gov/docs/
1998/Suppl-3/817-820suk/abstract.html
Key words: children, genetic, exposure, environment, susceptibility, genes, vulnerability,
developmental, risk
Introduction
The probability or risk of developing
childhood diseases is influenced not only by
genetic parameters, but by time, aging, and
one's exposure to environmental agents.
Exposures to environmental agents at
various stages ofa child's life from gestation
through young adulthood can confer differ-
ing opportunities for damage (Figure 1)
(1). Depending on the stage oflife, some
processes are more active or better con-
trolled than others. During fetal develop-
ment there is active cellular growth and
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development, which vary by trimester of
gestation. Brain development and certain
organ system development are very rapid
in the first trimester but slow down in the
final trimester. Certain enzyme systems
are developed and others are not.
Opportunities for mistakes in DNA repli-
cation are plentiful and DNA repair mech-
anisms in certain cells may not be mature.
The fetus is exquisitely sensitive to expo-
sures ofestrogens and other hormones that
are needed for growth and differentiation,
but environmental sources of endocrine-
disrupting chemicals may overload the sys-
tem and cause damage to the developing
organism (2). These effects may not be
apparent until adulthood.
After birth, the developing child may
be exposed to environmental agents in the
home, at day care, or in other environ-
ments that may impact on their develop-
ment (3). Although not as vulnerable as
the fetus, young children are also at risk
from adverse effects ofhigh doses oftoxi-
cants in their environment. For example,
children may be sensitive to the effects of
environmental tobacco smoke, air pollu-
tion, or allergens in the home, manifested
in pulmonary hyperreactivity and asthma
in susceptible subpopulations (4). Children
are very susceptible to the neurologic
effects oflead exposure. The brain and cen-
tral nervous system ofthe child continue to
develop for manyyears, and deficits in cog-
nitive development and learning-related
behaviors have been seen in children as old
as 11 to 14 years who have been exposed to
lead and polychlorinated biphenyls (5,6).
Puberty, with its concomitant changes
in hormone production, growth and
development of the sexual organs, and
physical growth, is a critical window of
vulnerability in adolescence. The mam-
mary gland may be especially susceptible
to the effects ofcigarette smoke, alcohol,
or organochlorine chemicals during this
period, conveying future risk of breast
cancer in adulthood (7). Receptor-medi-
ated cellular processes may be especially
vulnerable to changes during this period of
development. Vulnerability has direct con-
sequences for the risk ofdiseases ofchild-
hood as well as future risk of cancer or
other chronic diseases in adulthood.
Defining Genetic
Susceptibility
Because the human population is
biologically diverse and genetically hetero-
geneous, it is not surprising that differ-
ences in susceptibility to disease among
individuals with or without exposure to
Figure 1. Exposures to environmental agents can occur at various stages of a child's life. Exposure during critical
periods ofvulnerability can affect a child's risk of disease.
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environmental carcinogens should exist.
Individuals vary greatly in their suscepti-
bility to disease. Studies at the molecular
level in humans suggest that there is wide
interindividual variability in genetic
parameters, consistent with this differing
susceptibility to disease.
Recent discovery ofthe cystic fibrosis
gene, the gene for Duchenne's muscular
dystrophy, and a gene involved in the devel-
opment ofjuvenile onset diabetes opens the
door to new research on the etiology and
possible prevention of these diseases in
future generations. Other not so well-
known syndromes apparent in childhood,
such as Waardenberg syndrome, which
causes severe hearing loss in children, or
fragile X syndrome, which produces a cas-
cade ofdevelopmental delays and deficits
in children, have also been linked to dis-
tinct genes on somatic or sex-linked chro-
mosomes. These discoveries are critical to
our understanding ofgenetic susceptibility
ofdisease in children. Selected diseases of
childhood with known genetic links are
listed in Table 1.
To maintain the integrity ofthe genetic
material, cells have evolved complex mech-
anisms for repairing DNA damage. DNA
repair enzymes correct DNAdamage caused
by carcinogens, including the removal of
DNA adducts. Without correct repair of
DNA damage resulting from endogenous
and exogenous sources, the function ofthe
DNA to replicate and maintain cellular
function accurately would be compro-
mised. As such, continued introductions of
mutations into DNA can lead to increased
risks for developing cancer over time. By
studying individuals with multiple tumors,
hereditary conditions resulting in defective
DNA repair or chromosomal instability
have been identified that lead to increased
cancer risk. For example, xeroderma pig-
mentosum (XP) is an inherited condition
that involves defects in excision repair.
Individuals with this syndrome have extreme
photosensitivity and are at increased risk for
developing skin cancers (8). Children with
XP are kept out ofthe light to reduce their
Table 1. Genes and inherited childhood diseases.
Description Gene Chromosome
Ataxia telangiectasia ATM 11
Cystic fibrosis CFTR -7
Duchenne's muscular DMD X
dystrophy
Juvenile onset diabetes IDDMI 6
Phenylketonuria PAH 12
Waardenberg syndrome PAX3 2
risk ofdeveloping skin lesions. Another
genetic disease that may increase one's
susceptibility of future cancers is ataxia
telangiectasia (A-T). A-T is a rare hereditary
neurologic disorder that affects children. A
gene has been identified for this disorder; it
has also been determined that the function
ofthe normal protein is probably in the reg-
ulation ofcell division and also in apoptosis.
However, in addition to the neurologic
effects ofthis disease, patients with A-T and
A-T carriers have increased risks for devel-
oping cancers and are more sensitive to the
effects ofionizing radiation (9,10).
Perhaps the greatest advances in the
use of molecular tools to unravel gene-
environment interactions have developed
from the associations between exposure,
polymorphisms in carcinogen-metaboliz-
ing genes, and cancer risk. The enzymes
involved in carcinogen metabolism fall
into two broad categories: Phase I
enzymes, which almost exclusively involve
the cytochrome P450 gene superfamily
but also include N-acetyltransferase, are
involved in metabolic activation; and
phase II enzymes such as glutathione
S-transferases, which are involved in
detoxification reactions, are considered
protective pathways. Recent advances in
molecular DNA techniques have allowed
for the identification of polymorphisms
at the genetic level for several enzymes
important in carcinogen metabolism. The
induction of these enzyme systems varies
over one's lifetime.
The use ofmolecular DNA techniques,
including the development ofpolymerase
chain reaction-based methods, coupled
with our knowledge ofsome of the genes
in the multistage process of chemical
carcinogenesis, has aided in our ability to
study the genetic basis for the interindivid-
ual differences observed in populations. It
is the development ofthese techniques and
the search for critical target genes that has
guided epidemiologists in their quest to
explore gene-environment interactions in
human populations. Until now these
studies have been useful in furthering our
knowledge of carcinogenesis mainly in
adults. These techniques can be applied to
noncancer end points in populations of
children to understand the components of
genetic susceptibility and vulnerability to
environmental toxicants in diseases that
affect children. Biomarkers ofexposure,
effect, and susceptibility have been vali-
dated in adult studies. They are begin-
ning to be applied in studies, such as one
recently conducted in Poland (11), where
genotypes of mother-infant pairs of
individuals exposed to air pollution car-
cinogen were determined. These studies
showed a relationship between biomarkers
measuring pollutant exposure and suscepti-
bility and health end points such as birth
weight and head circumference in the
infants (11). These biomarkers will allow
the study ofthe interrelationship between
exposures and genetic factors at the molecu-
lar and cellular level. The time is right to
apply these exciting advances toward quan-
tifying the biologic dose ofenvironmentally
relevant exposures and to study these effects
in susceptible subgroups ofthe children.
Gene-Environment
Interaction: An Example
The study ofgene-environment interaction
is critical to fully understanding all ofthe
causal factors of disease in children.
Characterization ofgenetic polymorphism
ofimportant genes involved in the metabo-
lism ofenvironmental toxicants is also nec-
essary. Aspecific example ofresearch that is
applying these principles to the study ofan
exposure with enormous public health
importance to children follows. The charac-
terization ofa genetic polymorphism ofa
commonly occurring gene now allows pop-
ulation scientists to begin to understand the
relationship between lead exposure levels
and cognitive impairment in susceptible
subpopulations ofchildren.
The second enzyme ofthe heme biosyn-
thesis pathway, delta-aminolevulinate
dehydratase (ALAD), is a protein that is
encoded by a gene on the 9q34 chromo-
some. It is polymorphic in the population,
with two common alleles, ALAD-1 and
ALAD-2. This structure results in three dis-
tinct genotypes, ALAD 1-1, 1-2, and 2-2,
which are distributed in the population.
The alleles differ by a single base pair
change, a guanine to cytosine transversion
of coding nucleotide 177, which predicts
the substitution of an asparagine for a
lysine in the enzyme (12). The activity of
this enzyme has long been used in the
clinical diagnosis of lead poisoning, and
now the distribution in the population of
the gene that controls this enzyme can be
used to understand individual susceptibil-
ity to effects from exposure. It is hypothe-
sized that individuals with the ALAD-2
allele could be more susceptible to lead
exposure if the ALAD-2 subunit binds
lead more tightly than the ALAD-1 sub-
unit (13). Individuals with the ALAD 1-2
and 2-2 allele might have higher blood
lead concentrations as well as higher total
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body burden, making them more likely to
show clinical and subclinical manifesta-
tions oflow-level exposure. The ALAD-2
allele is typically found in 11 to 20% of
the white population (12,14), but it was
not detected in anAfrican population (15).
Work on this hypothesis began in a
population of male lead workers in a
German factory (16). Those workers who
were heterozygous and homozygous for the
ALAD-2 phenotype had higher average
lead levels that those workers who were
homozygous for ALAD-1 (17). There was
a difference in the median blood lead level
of 11 pg/dl between the workers with
ALAD-2 and ALAD-1 genotypes. In a
group ofenvironmentally exposed children
with blood lead levels lower than the work-
ing population, the same relationship was
found (17). There was a difference in the
median blood lead level of9 pg/dl found
between the two groups ofchildren.
In another study of occupationally
exposed carpenters, no difference was found
in blood lead levels with ALAD subtype
(18). These carpenters had much lower
exposures to lead than the other worker
studies. In the study conducted byWetmur
et al. (17), enrollment ofthe children in
the study was based on clinical screening of
free erythrocyte protoporphyrin (FEP) lev-
els. This screening may introduce a serious
selection bias into the study ifthere was
reduced sensitivity lead-induced FEP eleva-
tion within the ALAD-2 subgroup. This
bias would lead to a spurious association
with genetic trait because higher lead levels
would be required to be identified for
enrollment into thestudy. A recent study in
Korea indicates that ALAD-2 was overrep-
resented among individuals with blood lead
levels >40 pg/dl (19).
In another study, where a group of
adolescents with low-level lead exposure
were tested using a battery ofneuropsycho-
logic tests, inconclusive results were
obtained because only 5 ofthe 79 subjects
had the ALAD-2 genotype. In this study
ALAD status was inversely related to lead
levels in deciduous teeth. Performance on
the neurobehavioral tests was slightly better
inALAD-2 individuals (20).
This example provides some evidence
for heterogeneity in lead exposure levels
associated with genetic traits. One could
hypothesize that health effects would follow
the same relationship by genetic status.
There are no studies currently available
with the power to detect these important
effects. Continued research in the field of
lead is taking into account the discovery of
this parameter ofgenetic susceptibility
when studying the health effects in adults
and children. Genetic susceptibility
becomes increasingly important when low
levels of exposure are involved and the
health consequences may be subclinical.
Prevention and intervention programs
could be developed to target the susceptible
subpopulations. Evaluation ofmarkers of
genetic susceptibility may help make these
programs more effective.
Concluding Remarks
Opportunities exist for us to broaden our
understanding of the combined role of
genetics and the environment in the etiol-
ogy ofchildhood diseases. It is necessary to
apply what we have learned by studying
genetic susceptibility ofcancer and issues
ofgene-environment interactions in the
etiology of cancer to the study ofchild-
hood public health concerns. It is also nec-
essary to expand our knowledge of the
adult consequences ofexposures to impor-
tant environmental toxicants during the
vulnerable periods ofchildhood. As new
human disease genes are cloned and
advances are made in the understanding of
gene regulation of critical cellular and
molecular processes, new opportunities will
open up for the study ofnoncancer disease
end points.
Future research needs have been
identified, induding the following:
* Identify genetic markers ofdiseases of
children, i.e., asthma, learning and
behavior, birth defects
* Increase our understanding of the
developmental process ofcellular and
molecular processes during critical
periods ofvulnerability from the fetal
period through young adulthood, i.e.,
gene expression, enzyme regulation,
DNArepair
* Look for evidence of gene-environ-
ment interaction in studies of child-
hood diseases, i.e., lead andALAD
* Develop and utilize noninvasive tech-
niques to gather tissue for biomarkers
in children, i.e., buccal samples, cord
blood, placenta
* Develop arepository ofbiologicsamples
and exposure data from ongoing studies
ofchildren to be followed up as adults
* Expand our knowledge base of the
effects of exposure to environmental
exposures during childhood on the risk
ofadult diseases, i.e., effects ofprenatal
exposures to endocrine disruptors on
adult reproductive function, effects of
adolescent smoking on cancer risk
The biotechnologic revolution has
brought with it a myriad of advances
in understanding the human genome.
Continued pursuit in understanding how
the environment influences the risks of
human disease proscribed by our genetic
blueprints will bring us closer to under-
standing the etiology ofmany important
public health concerns ofchildren, our
most susceptible subpopulation.
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